The "Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions (January 15, 2026)" training has been added to ResearchAndMarkets.com's offering.

This expert-led 3-hour webinar provides a comprehensive introduction to the key regulatory pathways for medical device submissions in the US market.

The regulation and control of new or substantially changed medical devices for sale in the US is based on the 510(k), PMA or DeNovo submission process.

This webinar will discuss current US Federal law on the 510(k), IDE, DeNovo, and PMA and associated requirements for getting a new or substantially changed medical device through the US FDA review process and to market in the USA.

US law and the FDA require that a device be the subject of an approved marketing application before it is transported or distributed across state lines. Because a sponsor will probably want to ship an investigational device to clinical investigators in many states, it must seek an exemption from that legal requirement. The IDE is the means through which the sponsor technically obtains this exemption from the FDA.

The 510(k) program has recently been "modified" to encourage new technology and/or safer products to be submitted under the less severe 510(k) process to advance the state of the art, rather than the longer, more involved and more expensive PMA route when safety and efficacy issues remain substantially the same.

Why Should You Attend

For decades, the regulation and control of new or substantially changed medical devices for sale in the United States (no matter where manufactured has been based on the 510(k), PMA or DeNovo submission and FDA review process. A 510(k) clearance for Class II devices or a Pre Market Approval for Class III devices is required prior to commercialization. IDEs are for investigational devices prior to submission. And DeNovo is for less risky Class III devices that could possibly be Class II.

These submissions allow the FDA to review products as to substantial equivalence to existing products on the market (510(k)), or of a higher risk requiring clinicals (PMA). The 510(k) process has had some recent modification to allow for newer technology (Breakthrough) or increased safety (STeP). And new Machine Learning and Artificial Intelligence features add additional complexity to the process. The data gathered during any human clinical trials of a device under an Investigational Device Exemption (IDE) becomes part of some submissions, primarily the PMA.

Who Should Attend:

• Senior Management in Medical Devices and Combination Products
• Quality Assurance (QA) and Regulatory Affairs (RA) Professionals
• Medical Device Product Development Teams
• Research & Development (R&D) Specialists
• Engineering Teams
• Production and Manufacturing Personnel
• Operations Managers
• Marketing Professionals involved in Medical Devices
• Consultants and Others involved in:
• Drug product development
• Manufacturing processes
• Process, product, and data analysis
• Regulatory submission and compliance responsibilities

Key Topics Covered:

Introduction to Device Submissions and the US FDA

• Overview of the FDA's role in medical device regulation and the different submission pathways.

The 510(k) Process

• Step-by-step explanation of the 510(k) premarket notification process, key requirements, and best practices.

The IDE (Investigational Device Exemption) Process

• Understanding when and how to submit an IDE to conduct clinical investigations in the US.

The PMA (Premarket Approval) Process

• In-depth look at the PMA process for high-risk devices, including data requirements and review steps.

The De Novo Process

• Exploring the pathway for novel low- to moderate-risk devices that lack a predicate.

New 510(k) Mod Program and Q-Sub Process

• Overview of the streamlined 510(k) modification program and the Q-Submission (Q-Sub) process for early FDA interactions.

Machine Learning and Artificial Intelligence (AI) Issues - FDA Principles

• Discussion on current FDA guidance related to AI/ML-based medical devices and regulatory considerations.

Post-Market Requirements

• Key post-market surveillance, reporting, and compliance requirements for medical devices after FDA clearance/approval.

Speakers:

John E Lincoln

Principal

J. E. Lincoln and Associates LLC

John E. Lincoln is Principal of J. E. Lincoln and Associates LLC, a consulting company, with over 32 years experience in U.S. FDA-regulated industries, 18 of which as a full time independent FDA-regulated industry consultant. Mr. Lincoln has worked with companies from start-up to Fortune 100, in the U.S., Mexico, Canada, France, Germany, Sweden, China and Taiwan. He specializes in quality assurance, regulatory affairs, QMS / CGMP audits and problem remediation and FDA responses, new / changed product 510(k)s, process / product / equipment including QMS and software validations, ISO 14971 product risk management files / reports, Design Control / Design History Files, Technical Files. He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D).

In addition, he has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer reviewed journals, conducted workshops and webinars worldwide on CAPA, 510(k)s, risk analysis / management, FDA / GMP audits, validation, root cause analysis, and others. He is a graduate of UCLA.

For more information about this training visit https://www.researchandmarkets.com/r/nwcdzi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260114899187/en/